Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001102578-22-000036
Filing Date
2022-02-11
Accepted
2022-02-10 17:37:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 MYRIAD GENETICS, INC. - 12/31/2021 mygn13g1st1221.txt SC 13G/A 8936
  Complete submission text file 0001102578-22-000036.txt   10400
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 22615546
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1180 PEACHTREE STREET NE, SUITE 2300 ATLANTA GA 30309
Business Address 1180 PEACHTREE STREET NE, SUITE 2300 ATLANTA GA 30309 4048158772
EARNEST PARTNERS LLC (Filed by) CIK: 0001102578 (see all company filings)

EIN.: 582386669 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A